WE DISCOVER AND DEVELOP NOVEL AND
DIFFERENTIATED THERAPIES IN CANCER AND BEYOND
ADDRESS UNMET MEDICAL NEEDS FOR PATIENTS IN CHINA AND GLOBALLY
Founded in 2016, we have established a robust in-house R&D engine underpinned by an outstanding discovery team and a multi-dimensional discovery platform. We have strategically designed and developed a rich pipeline of 10+ small molecule programs focused on oncology.